• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解抑郁症的负担。

Understanding the burden of depression.

机构信息

Department of Family Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.

出版信息

J Clin Psychiatry. 2011 Jun;72(6):e19. doi: 10.4088/JCP.10126tx1c.

DOI:10.4088/JCP.10126tx1c
PMID:21733472
Abstract

Major depressive disorder is a highly prevalent, chronic, and disabling disease affecting millions of individuals worldwide. The burden of major depressive disorder includes impaired role functioning, decreased quality of life, the development of medical conditions, and increased morbidity and mortality. The long-term, recurrent nature of depression and its frequent resistance to available therapies lead to increased utilization of health services, which represents a large financial burden in health care costs. Major depressive disorder is often undertreated; however, even when treatment is adequate, remission rates are low and partial response is common.

摘要

重度抑郁症是一种在全球范围内影响数百万人的高发性、慢性和致残性疾病。重度抑郁症的负担包括角色功能受损、生活质量下降、引发医疗状况以及发病率和死亡率增加。抑郁的长期性、复发性及其对现有治疗方法的频繁抵抗导致卫生服务的利用增加,这在医疗保健成本方面构成了巨大的经济负担。重度抑郁症常常治疗不足;然而,即使治疗充分,缓解率也很低,部分反应很常见。

相似文献

1
Understanding the burden of depression.了解抑郁症的负担。
J Clin Psychiatry. 2011 Jun;72(6):e19. doi: 10.4088/JCP.10126tx1c.
2
The human cost of not achieving full remission in depression.抑郁症未实现完全缓解所带来的人力成本。
Can J Psychiatry. 2004 Mar;49(3 Suppl 1):10S-16S.
3
The burden of disease for treatment-resistant depression.难治性抑郁症的疾病负担。
J Clin Psychiatry. 2001;62 Suppl 16:26-31.
4
Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder.无反应、部分反应及未实现缓解:重度抑郁症的人文负担与成本负担
Depress Anxiety. 2009;26(1):83-97. doi: 10.1002/da.20505.
5
Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.雇主承担轻度、中度和重度重度抑郁症的负担:精神卫生服务的利用和成本,以及工作表现。
Depress Anxiety. 2010;27(1):78-89. doi: 10.1002/da.20580.
6
Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden.抑郁症治疗临床指南,I. 定义、患病率及健康负担。
Can J Psychiatry. 2001 Jun;46 Suppl 1:13S-20S.
7
Cost of depression among adults in Japan in 2005.2005 年日本成年人抑郁症的成本。
Psychiatry Clin Neurosci. 2011 Aug;65(5):442-50. doi: 10.1111/j.1440-1819.2011.02237.x.
8
The societal costs of chronic major depression.慢性重度抑郁症的社会成本。
J Clin Psychiatry. 2001;62 Suppl 6:5-9.
9
Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial.抑郁症质量改善成本效益的性别模式:一项随机对照试验的结果
J Affect Disord. 2005 Aug;87(2-3):319-25. doi: 10.1016/j.jad.2005.03.018.
10
Cost-effectiveness of improving primary care treatment of late-life depression.改善老年抑郁症初级护理治疗的成本效益。
Arch Gen Psychiatry. 2005 Dec;62(12):1313-20. doi: 10.1001/archpsyc.62.12.1313.

引用本文的文献

1
Sex Differences in Suicide Attempts: A Cross-Sectional Study in Patients with First-Episode and Drug-Naïve Major Depression Disorder.自杀未遂的性别差异:首发未用药的重度抑郁症患者的横断面研究
Depress Anxiety. 2024 Jul 26;2024:5391546. doi: 10.1155/2024/5391546. eCollection 2024.
2
Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients.肥胖和代谢失调患者抑郁症治疗中ω-3脂肪酸的个性化医疗
J Pers Med. 2023 Jun 15;13(6):1003. doi: 10.3390/jpm13061003.
3
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review.
谷氨酸介导的抗抑郁反应的内在连接网络:一项神经影像学综述。
Front Psychiatry. 2022 May 26;13:864902. doi: 10.3389/fpsyt.2022.864902. eCollection 2022.
4
Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection.营养、表观遗传学与重度抑郁症:理解它们之间的联系
Front Nutr. 2022 May 18;9:867150. doi: 10.3389/fnut.2022.867150. eCollection 2022.
5
Psychometric Properties of the Chinese Version of the Clinically Useful Depression Outcome Scale for Patients with Major Depressive Disorder.《用于重度抑郁症患者的临床实用抑郁结果量表中文版的心理测量学特性》
Neuropsychiatr Dis Treat. 2021 Jul 21;17:2387-2395. doi: 10.2147/NDT.S307662. eCollection 2021.
6
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.谷氨酸能神经传递:开发新型快速作用抗抑郁治疗方法的途径。
Int J Neuropsychopharmacol. 2019 Feb 1;22(2):119-135. doi: 10.1093/ijnp/pyy094.
7
Aberrant Global and Regional Topological Organization of the Fractional Anisotropy-weighted Brain Structural Networks in Major Depressive Disorder.重度抑郁症患者分数各向异性加权脑结构网络的异常全局和区域拓扑组织
Chin Med J (Engl). 2016 Mar 20;129(6):679-89. doi: 10.4103/0366-6999.178002.
8
Blood BDNF level is gender specific in severe depression.在重度抑郁症中,血液中脑源性神经营养因子(BDNF)水平存在性别差异。
PLoS One. 2015 May 26;10(5):e0127643. doi: 10.1371/journal.pone.0127643. eCollection 2015.
9
Anomalous gray matter structural networks in major depressive disorder.重度抑郁症中的异常灰质结构网络。
Biol Psychiatry. 2013 Nov 15;74(10):777-85. doi: 10.1016/j.biopsych.2013.03.005. Epub 2013 Apr 18.
10
Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention.治疗抵抗性抑郁症的死亡率和自杀风险:干预长期影响的观察性研究。
PLoS One. 2012;7(10):e48002. doi: 10.1371/journal.pone.0048002. Epub 2012 Oct 25.